People who take weight-loss drugs based on GLP-1 receptor agonists seem to have reduced risk for a litany of diseases, including Alzheimer's, but an increase in some other conditions like kidney ...

When you buy through our links, Business Insider may earn an affiliate commission. Learn more Spring is a prime opportunity to check on your jewelry box and see what your collection is missing. Could ...